An interventional study of allergy test in Food Protein Induced Enterocolitis Syndrome (FPIES), sponsored by Fondation Lenval. Recruiting at 19 sites in France. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2023-09-29.
Sponsored by Fondation Lenval · Not applicable, Interventional, and Diagnostic
Food protein induced enterocolitis syndrome (FPIES), is a non-IgE mediated food allergy (FA) which seems to expand, and occurring in infancy. This disease is usually unknown by clinicians. In 2017, an international workgroup of American Academy of Allergy, Asthma and Immunology published clinical criteria to specify the diagnosis. However, there is a lack of information in literature for describe the evolution and atypical phenotypes. In addition, no prospective French series has been published to date. The aim of the study is to collect clinical features and allergy testing of children who have acute form of FPIES at diagnosis and during evolution during three years
Food protein induced enterocolitis syndrome (FPIES), is a non-IgE mediated food allergy (FA) which seems to expand, and occurring in infancy. Prevalence of FPIES is unknown. In 2011, Katz published cumulative incidence of cow 'milk FPIES of 3 per 1000 new-borns, from prospective birth cohort in Israel.
The offending food depend on the country, probably in relation to eating habits.
Cow's milk (CM) is most commonly incriminated and can lead to a chronic digestive disease or in its acute form with potentially life-threatening vomiting/diarrhoea/dehydration, confusing with anaphylaxis. Rice and oat in US, or fish and egg in France are the solid food most often implicated.
This disease is usually unknown by clinicians. Its diagnostic is based on clinical history, and differential diagnosis elimination.
In 2017, an international workgroup of American Academy of Allergy, Asthma and Immunology published clinical criteria to specify the diagnosis and management. According to this last definition (JACI 2017), patient have to meet the major criterion and at least 3 minor criteria. Major criterion is vomiting in the 1- to 4-h period after ingestion of the suspect food and absence of classic IgE-mediated allergic skin or respiratory symptoms. Minor criteria are :
The age of tolerance, depend of the food. The average age of acquiring tolerance for cow's milk changes in the literature, around 8-10 months in Korea, around 1 year in Israel, around 5 years in the United States. There is no data in France on the recovery age of CM-FPIES.
However, there is a lack of information in literature for describe the evolution and atypical phenotypes. In addition, no prospective French series has been published to date.
Our work is a national prospective study, which will collect news cases of acute FPIES diagnosis in sixteen French centres.
Main objective: To determine the rate of acquisition of tolerance by food at 1 year, 2 years, 3 years post inclusion.
Secondary objectives:
Description of a population of children with newly diagnosed FPIES. 2. Describe the rate of patients with FPIES progressing to IgE sensitization whatever the food at 1 year, 2 years, 3 years post inclusion.
The inclusion period will last three years, and the follow up of each patient will last three years.
Allergologist will see the patient at inclusion visit, then one time a year. If the patient does not acquire tolerance, an oral food challenge (OFC) in hospital will lead to answer.
The aim of our work will help allergologist to manage FPIES children, with French specificities in offending food, and tolerance.
21 studies on the registry are indexed under Enterocolitis; 3 are open to participants now.
This study's planned enrollment of 600 is above the median of 75 across 14 interventional studies indexed under Enterocolitis.
Browse Enterocolitis studies →Fondation Lenval is the lead sponsor of 61 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Diagnostic Test: allergy test
allergy test are oral food challenge , prick test and IgE blood rate
tolerance acquisition
The acquisition of tolerance will be defined by negative OFC or accidental intake of the food at home tolerated according to parents discussion
Time frame: through study completion, an average of 6 years
population description
The description of the population included will be made according to the clinical, the demographic data, the allergy tests, the history of the disease
Time frame: through study completion, an average of 6 years
IgE sensitization
IgE sensitization is defined by the positivity of an immediate-read skin test (wheal of the prick test greater than half of the positive histamine control) and/or the presence of specific IgE antibody on a blood sample (≥0.35 kU/L).
Time frame: at 1 year, 2 years, 3 years post inclusion
food sensitization
food sensitization is defined by the positivity of an immediate-read skin test (wheal of the prick test greater than half of the positive histamine control)
Time frame: at 1 year, 2 years, 3 years post inclusion
IgE-mediated allergy
IgE-mediated allergy is defined by the demonstration of clinical symptoms related to the presence of these specific IgEs.
Time frame: at 1 year, 2 years, 3 years post inclusion
IgE-dependent allergy
IgE-dependent allergy will be defined by the appearance of symptoms a few minutes to 2 hours after ingestion of the food, with skin signs (urticaria, angioedema) and/or respiratory symptoms (dyspnea, laryngospasm, cough, bronchospasm ); digestive and neurological signs being potentially common with the diagnosis of FPIES
Time frame: at 1 year, 2 years, 3 years post inclusion
multiple FPIES
A multiple FPIES will be defined by the presence of clinical symptoms of FPIES for at least two different foods
Time frame: at 1 year, 2 years, 3 years post inclusion
Atopic comorbidities
Atopic comorbidities will be defined by asthma, allergic rhinitis, atopic dermatitis, and eosinophilic esophagitis
Time frame: at 1 year, 2 years, 3 years post inclusion
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fondation Lenval